CVRX CVRx, Inc. - Common Stock
NASDAQ · Health Care · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 6, 2026
$1.55
· % 处于52周区间
· 高于低点
· 至高点
$1.5052周低点
$11.3052周高点
市值 (MRQ)
$41M
P/E (TTM)
-0.8
EPS (TTM)
$-1.97
收入 (TTM)
$61M
CVRX 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$1.55
市值 (MRQ)
$41M
P/E (TTM)
-0.8
EPS (TTM)
$-1.97
收入 (TTM)
$61M
ROE (TTM)
-133.4%
负债/权益 (MRQ)
2.9
52周区间
$2–$11
CVRX 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
关于 CVRx, Inc. - Common Stock 公司概况（来自维基百科）
行业板块Health Care
行业Health Care
员工223
国家US
10年表现 收入、净利润、利润率和每股收益趋势
收入$57M2020-12-31 → 2025-12-31
EPS$-2.042021-12-31 → 2025-12-31
自由现金流$-41M2021-12-31 → 2025-12-31
净利率-84.9%2021-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | CVRX | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | -0.85年均值 ≈-7.2 | ≈-7.2 | · | · | |
| P/S (TTM) | 0.75年均值 ≈12.4 | ≈12.4 | 2.2 | 公允价值 | |
| 市净率 (MRQ) | 2.15年均值 ≈4.6 | ≈4.6 | 3.8 | 估值过高 | |
| EV / EBITDA (企业价值 / EBITDA) | -0.35年均值 ≈-6.4 | ≈-6.4 | · | · | |
| 股价/自由现金流 (TTM) | -1.05年均值 ≈-9.3 | ≈-9.3 | · | · | |
| 市现率 (TTM) | -1.05年均值 ≈-9.5 | ≈-9.5 | · | · | |
| EV / Revenue (市值/营收) | 0.35年均值 ≈8.8 | ≈8.8 | · | · | |
| EV / FCF (市值/自由现金流) | -0.45年均值 ≈-7.1 | ≈-7.1 | · | · | |
| Price / Tangible Book (市净率（有形资产）) | 1.05年均值 ≈4.6 | ≈4.6 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | CVRX | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 毛利率 (TTM) | 86.9%5年均值 ≈80.6% | ≈80.6% | 37.9% | 顶尖 | |
| 营业利润率 (TTM) | -79.5%5年均值 ≈-140.9% | ≈-140.9% | -18.1% | 弱 | |
| EBITDA Margin (息税折旧摊销前利润率) | -90.5%5年均值 ≈-140.9% | ≈-140.9% | -17.5% | 弱 | |
| 税前利润率 (TTM) | -84.9%5年均值 ≈-165.8% | ≈-165.8% | -11.6% | 弱 | |
| 净利润率 (TTM) | -84.9%5年均值 ≈-166.1% | ≈-166.1% | -50.8% | 低于平均水平 | |
| ROA (TTM) | -49.1%5年均值 ≈-39.4% | ≈-39.4% | -13.7% | 弱 | |
| ROE (TTM) | -133.4%5年均值 ≈-62.9% | ≈-62.9% | -81.1% | 弱 | |
| ROIC | -57.7%5年均值 ≈-40.6% | ≈-40.6% | -16.7% | 弱 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | CVRX | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 负债/股东权益比率 (MRQ) | 2.95年均值 ≈0.5 | ≈0.5 | 1.8 | 高于平均水平 | |
| 流动比率 (MRQ) | 8.05年均值 ≈14.9 | ≈14.9 | 2.7 | 流动性强 | |
| Quick Ratio (速动比率) | 6.55年均值 ≈13.6 | ≈13.6 | 1.9 | 流动性强 | |
| 长期负债/股东权益 (MRQ) | 2.95年均值 ≈0.5 | ≈0.5 | 2.9 | 持平 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | CVRX | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 10.4%5年均值 ≈60.7% | ≈60.7% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 36.1%5年均值 ≈60.2% | ≈60.2% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | 56.4% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | CVRX | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.55年均值 ≈0.3 | ≈0.3 | 0.7 | 弱 | |
| Inventory Turnover (库存周转率) | 0.75年均值 ≈0.8 | ≈0.8 | 2.3 | 弱 | |
| Receivables Turnover (应收账款周转率) | 5.75年均值 ≈6.0 | ≈6.0 | 5.8 | 持平 | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$254.0K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
1.1%
下次报告
十一月 03, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 3, 2026 | $-0.53 | $-0.53 | 0.90% |
| 2026年3月31日 | $-0.50 | $-0.51 | 2.8% | |
| 2025年12月31日 | $-0.46 | $-0.45 | -2.8% | |
| 2025年9月30日 | $-0.49 | $-0.51 | 4.2% | |
| 2025年6月30日 | $-0.57 | $-0.53 | -7.5% | |
| 2025年3月31日 | $-0.53 | $-0.58 | 8.8% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $57M | $51M | $39M | $22M | $13M | $6M | |
| Cost of Revenue | $8M | $8M | $6M | $5M | $4M | $1M | |
| Gross Profit | $48M | $43M | $33M | $17M | $9M | $5M | |
| R&D Expense | $11M | $11M | $12M | $10M | $8M | $6M | |
| SG&A Expense | $88M | $91M | $65M | $50M | $28M | $10M | |
| Operating Expenses | $100M | $102M | $76M | $60M | $35M | $16M | |
| Operating Income | $-51M | $-59M | $-43M | $-43M | $-26M | $-12M | |
| Interest Expense | · | · | $2M | $165.0K | $2M | $2M | |
| Other Non-op | $4M | $4M | $4M | $1M | $-15M | $-40.0K | |
| Pretax Income | $-53M | $-60M | $-41M | $-41M | $-43M | $-14M | |
| Income Tax | $-18.0K | $55.0K | $147.0K | $109.0K | $91.0K | $85.0K | |
| Net Income | $-53M | $-60M | $-41M | $-41M | $-43M | $-14M | |
| EPS (Basic) | $-2.04 | $-2.65 | $-1.99 | $-2.02 | $-4.16 | · | |
| EPS (Diluted) | $-2.04 | $-2.65 | $-1.99 | $-2.02 | $-4.16 | · | |
| Shares (Basic) | 26,084,709 | 22,596,229 | 20,754,375 | 20,532,838 | 10,360,054 | · | |
| Shares (Diluted) | 26,084,709 | 22,596,229 | 20,754,375 | 20,532,838 | 10,360,054 | · | |
| EBITDA | $-51M | $-59M | $-43M | $-43M | $-26M | · |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $76M | $106M | $91M | $106M | $142M | $59M | |
| Receivables | $11M | $9M | $8M | $6M | $3M | $1M | |
| Inventory | $12M | $12M | $11M | $7M | $4M | $3M | |
| Prepaid Expense | $3M | $3M | $3M | $4M | $3M | $605.0K | |
| Current Assets | $102M | $130M | $112M | $123M | $151M | $64M | |
| PP&E (Net) | $2M | $3M | $2M | $2M | $1M | $410.0K | |
| PP&E (Gross) | $6M | $6M | $5M | $4M | $3M | $2M | |
| Accum. Depreciation | $4M | $3M | $3M | $2M | $2M | $2M | |
| Other Non-current Assets | $26.0K | $27.0K | $27.0K | $27.0K | $26.0K | $26.0K | |
| Total Assets | $105M | $133M | $115M | $125M | $153M | $65M | |
| Accounts Payable | $4M | $3M | $2M | $2M | $510.0K | $483.0K | |
| Accrued Liabilities | $9M | $8M | $6M | $6M | $5M | $4M | |
| Current Liabilities | $13M | $11M | $8M | $8M | $6M | $8M | |
| Capital Leases | $638.0K | $877.0K | $1M | $117.0K | $0 | · | |
| Other Non-current Liabilities | $2M | $1M | $1M | $805.0K | $681.0K | $777.0K | |
| Total Liabilities | $65M | $62M | $39M | $16M | $7M | $28M | |
| Long-term Debt | · | · | · | · | · | $19M | |
| Total Debt | $50M | $49M | $29M | $7M | $0 | · | |
| Common Stock | $263.0K | $253.0K | $209.0K | $207.0K | $204.0K | $4.0K | |
| Retained Earnings | $-591M | $-537M | $-477M | $-436M | $-395M | $-352M | |
| AOCI | $-203.0K | $-206.0K | $-207.0K | $-207.0K | $-198.0K | $-190.0K | |
| Stockholders' Equity | $39M | $71M | $76M | $109M | $146M | $-293M | |
| Liabilities + Equity | $105M | $133M | $115M | $125M | $153M | $65M | |
| Shares Outstanding | 26,311,607 | 25,324,684 | 20,879,199 | 20,663,736 | 20,399,337 | 360,412 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $11M | $19M | $6M | $4M | $2M | $132.0K | |
| Operating Cash Flow | $-40M | $-39M | $-39M | $-43M | $-28M | $-16M | |
| CapEx | $580.0K | $1M | $591.0K | $685.0K | $1M | $311.0K | |
| Investing Cash Flow | $-580.0K | $-1M | $-591.0K | $-685.0K | $-1M | $-311.0K | |
| Net Debt Issued | · | · | · | $0 | $-21M | · | |
| Stock Issued | $9M | $33M | $0 | $0 | $133M | $0 | |
| Net Stock Activity | $9M | $33M | · | $0 | $133M | · | |
| Financing Cash Flow | $11M | $56M | $24M | $7M | $112M | $50M | |
| Net Change in Cash | $-30M | $15M | $-16M | $-36M | $83M | $33M | |
| Free Cash Flow | $-41M | $-41M | $-40M | $-43M | $-29M | · | |
| Levered FCF | · | · | $-41M | $-44M | $-31M | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 85.3% | 83.8% | 84.1% | 77.8% | 72.1% | · | |
| Operating Margin | -90.5% | -116.0% | -109.7% | -189.3% | -199.2% | · | |
| Net Margin | -94.1% | -116.9% | -104.8% | -184.4% | -330.4% | · | |
| Pretax Margin | -94.1% | -116.8% | -104.5% | -183.9% | -329.8% | · | |
| EBITDA Margin | -90.5% | -116.0% | -109.7% | -189.3% | -199.2% | · | |
| ROA | -44.8% | -48.2% | -34.3% | -29.9% | -39.6% | · | |
| ROE | -109.6% | -88.0% | -51.9% | -36.4% | -28.5% | · | |
| ROIC | -57.7% | -49.5% | -41.1% | -36.8% | -17.8% | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 7.6 | 12.1 | 14.3 | 15.2 | 25.6 | · | |
| Quick Ratio | 6.5 | 10.7 | 12.5 | 13.8 | 24.5 | · | |
| Debt / Equity | 1.3 | 0.7 | 0.4 | 0.1 | 0.0 | · | |
| LT Debt / Equity | 1.3 | 0.7 | 0.4 | 0.1 | 0.0 | · | |
| Interest Coverage | · | · | -24.0 | -257.7 | -11.7 | · |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.4 | 0.3 | 0.2 | 0.1 | · | |
| Inventory Turnover | 0.7 | 0.7 | 0.7 | 0.9 | 1.0 | · | |
| Receivables Turnover | 5.7 | 6.1 | 6.0 | 5.6 | 6.8 | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.49 | $2.81 | $3.64 | $5.29 | $7.16 | · | |
| Revenue / Share | $2.17 | $2.27 | $1.89 | $1.09 | · | · | |
| Cash Flow / Share | $-1.54 | $-1.73 | $-1.88 | $-2.08 | · | · | |
| Cash / Share | $2.88 | $4.18 | $4.34 | $5.15 | $6.96 | · | |
| EPS (TTM) | $-2.04 | $-2.65 | $-1.99 | $-2.02 | $-4.16 | · |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.4% | 30.5% | 74.9% | 72.4% | 115.4% | · | |
| Revenue CAGR 3Y | 36.1% | 57.9% | 86.6% | · | · | · | |
| Revenue CAGR 5Y | 56.4% | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $57M | $51M | $39M | $22M | $13M | · | |
| Net Income TTM | $-53M | $-60M | $-41M | $-41M | $-43M | · | |
| Market Cap | $187M | $321M | $656M | $379M | $249M | · | |
| Enterprise Value | $161M | $264M | $595M | $279M | $107M | · | |
| P/E | -3.5 | -4.8 | -15.8 | -9.1 | -2.9 | · | |
| P/S | 3.3 | 6.3 | 16.7 | 16.9 | 19.1 | · | |
| P/B | 4.8 | 4.5 | 8.6 | 3.5 | 1.7 | · | |
| P / Tangible Book | 4.8 | 4.5 | 8.6 | 3.5 | 1.7 | · | |
| P / Cash Flow | -4.7 | -8.2 | -16.8 | -8.9 | -9.0 | · | |
| P / FCF | -4.6 | -7.9 | -16.6 | -8.7 | -8.6 | · | |
| EV / EBITDA | -3.1 | -4.4 | -13.8 | -6.6 | -4.1 | · | |
| EV / FCF | -3.9 | -6.5 | -15.0 | -6.4 | -3.7 | · | |
| EV / Revenue | 2.8 | 5.2 | 15.1 | 12.4 | 8.2 | · | |
| Earnings Yield | -28.7% | -20.9% | -6.3% | -11.0% | -34.0% | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16M | $15M | $16M | $15M | $14M | $12M | $15M | $13M | $12M | $11M | $11M | $11M | $10M | $8M | $7M | $6M | |
| Cost of Revenue | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $1M | |
| Gross Profit | $14M | $13M | $14M | $13M | $11M | $10M | $13M | $11M | $10M | $9M | $10M | $9M | $8M | $7M | $6M | $5M | |
| R&D Expense | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $2M | |
| SG&A Expense | $24M | $22M | $22M | $22M | $23M | $21M | $20M | $22M | $21M | $28M | $17M | $16M | $16M | $15M | $14M | $13M | |
| Operating Expenses | $27M | $25M | $25M | $25M | $26M | $24M | $23M | $24M | $24M | $31M | $19M | $18M | $20M | $19M | $17M | $15M | |
| Operating Income | $-13M | $-12M | $-11M | $-12M | $-14M | $-13M | $-10M | $-13M | $-14M | $-22M | $-10M | $-10M | $-12M | $-12M | $-11M | $-10M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $960.0K | · | $499.0K | $481.0K | $240.0K | $165.0K | $0 | |
| Other Non-op | $560.0K | $593.0K | $660.0K | $875.0K | $1M | $1M | $1M | $917.0K | $944.0K | $1M | $1M | $1M | $616.0K | $1M | $1M | $328.0K | |
| Pretax Income | $-14M | $-13M | $-12M | $-13M | $-15M | $-14M | $-11M | $-13M | $-14M | $-22M | $-9M | $-9M | $-12M | $-11M | $-11M | $-10M | |
| Income Tax | $3.0K | $1.0K | $-7.0K | $-3.0K | $-3.0K | $-5.0K | $-71.0K | $47.0K | $41.0K | $38.0K | $39.0K | $40.0K | $34.0K | $34.0K | $28.0K | $32.0K | |
| Net Income | $-14M | $-13M | $-12M | $-13M | $-15M | $-14M | $-11M | $-13M | $-14M | $-22M | $-9M | $-9M | $-12M | $-11M | $-11M | $-10M | |
| EPS (Basic) | $-0.53 | $-0.50 | $-0.45 | $-0.49 | $-0.57 | $-0.53 | $-0.39 | $-0.57 | $-0.65 | $-1.04 | $-0.45 | $-0.43 | $-0.56 | $-0.55 | $-0.51 | $-0.48 | |
| EPS (Diluted) | $-0.53 | $-0.50 | $-0.45 | $-0.49 | $-0.57 | $-0.53 | $-0.39 | $-0.57 | $-0.65 | $-1.04 | $-0.45 | $-0.43 | $-0.56 | $-0.55 | $-0.51 | $-0.48 | |
| Shares (Basic) | 26,515,442 | 26,355,591 | · | 26,168,562 | 26,071,316 | 25,876,062 | · | 22,783,337 | 21,628,542 | 21,232,009 | · | 20,801,350 | 20,711,850 | 20,693,224 | · | 20,576,838 | |
| Shares (Diluted) | 26,515,442 | 26,355,591 | · | 26,168,562 | 26,071,316 | 25,876,062 | · | 22,783,337 | 21,628,542 | 21,232,009 | · | 20,801,350 | 20,711,850 | 20,693,224 | · | 20,576,838 | |
| EBITDA | $-13M | $-12M | · | $-12M | $-14M | $-13M | · | $-13M | $-14M | $-22M | · | $-10M | $-12M | $-12M | · | $-10M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $65M | $72M | $76M | $85M | $95M | $103M | $106M | $100M | $70M | $80M | $91M | $83M | $91M | $103M | $106M | $110M | |
| Receivables | $9M | $9M | $11M | $8M | $7M | $9M | $9M | $9M | $9M | $8M | $8M | $6M | $7M | $6M | $6M | $5M | |
| Inventory | $13M | $12M | $12M | $11M | $12M | $12M | $12M | $12M | $11M | $11M | $11M | $11M | $11M | $8M | $7M | $6M | |
| Prepaid Expense | $2M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $4M | $3M | $4M | $3M | |
| Current Assets | $89M | $97M | $102M | $108M | $116M | $126M | $130M | $124M | $92M | $102M | $112M | $104M | $112M | $121M | $123M | $124M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | $5M | $5M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | |
| Accum. Depreciation | $3M | $3M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | |
| Other Non-current Assets | $26.0K | $26.0K | $26.0K | $26.0K | $26.0K | $26.0K | $27.0K | $26.0K | $26.0K | $26.0K | $27.0K | $26.0K | $27.0K | $27.0K | $27.0K | $26.0K | |
| Total Assets | $92M | $100M | $105M | $111M | $120M | $130M | $133M | $128M | $96M | $106M | $115M | $106M | $115M | $123M | $125M | $127M | |
| Accounts Payable | $4M | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $4M | $3M | $2M | $1M | $3M | $2M | $2M | $1M | |
| Accrued Liabilities | $7M | $6M | $9M | $8M | $7M | $6M | $8M | $8M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | |
| Current Liabilities | $11M | $9M | $13M | $11M | $10M | $9M | $11M | $11M | $9M | $8M | $8M | $7M | $9M | $8M | $8M | $7M | |
| Capital Leases | $448.0K | $544.0K | $638.0K | $730.0K | $819.0K | $802.0K | $877.0K | $951.0K | $1M | $1M | $1M | $916.0K | $946.0K | $59.0K | $117.0K | $175.0K | |
| Other Non-current Liabilities | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $960.0K | $885.0K | $815.0K | $805.0K | $761.0K | |
| Total Liabilities | $72M | $71M | $65M | $63M | $62M | $60M | $62M | $62M | $41M | $40M | $39M | $24M | $25M | $23M | $16M | $8M | |
| Total Debt | $59M | $58M | · | $49M | $49M | $49M | · | $49M | $29M | $29M | · | $14M | $14M | $14M | · | · | |
| Common Stock | $266.0K | $264.0K | $263.0K | $262.0K | $261.0K | $261.0K | $253.0K | $242.0K | $217.0K | $216.0K | $209.0K | $208.0K | $208.0K | $207.0K | $207.0K | $206.0K | |
| Retained Earnings | $-618M | $-604M | $-591M | $-579M | $-566M | $-551M | $-537M | $-527M | $-514M | $-500M | $-477M | $-468M | $-459M | $-448M | $-436M | $-426M | |
| AOCI | $-204.0K | $-203.0K | $-203.0K | $-204.0K | $-203.0K | $-205.0K | $-206.0K | $-208.0K | $-210.0K | $-210.0K | $-207.0K | $-208.0K | $-187.0K | $-204.0K | $-207.0K | $-219.0K | |
| Stockholders' Equity | $20M | $29M | $39M | $48M | $58M | $69M | $71M | $65M | $55M | $66M | $76M | $83M | $90M | $100M | $109M | $118M | |
| Liabilities + Equity | $92M | $100M | $105M | $111M | $120M | $130M | $133M | $128M | $96M | $106M | $115M | $106M | $115M | $123M | $125M | $127M | |
| Shares Outstanding | 26,641,597 | 26,428,767 | 26,311,607 | 26,193,733 | 26,145,951 | 26,051,992 | 25,324,684 | 24,203,658 | 21,712,357 | 21,593,173 | 20,879,199 | 20,813,612 | 20,750,910 | 20,708,940 | 20,663,736 | 20,578,963 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $11M | $2M | $2M | $1M | $2M | $1M | $929.0K | |
| Operating Cash Flow | $-9M | $-12M | $-10M | $-10M | $-8M | $-13M | $-8M | $-10M | $-10M | $-11M | $-8M | $-8M | $-13M | $-10M | $-11M | $-11M | |
| CapEx | $112.0K | $122.0K | $68.0K | $295.0K | $103.0K | $114.0K | $52.0K | $37.0K | $355.0K | $917.0K | $169.0K | $39.0K | $143.0K | $240.0K | $79.0K | $264.0K | |
| Investing Cash Flow | $-112.0K | $-122.0K | $-68.0K | $-295.0K | $-103.0K | $-114.0K | $-52.0K | $-37.0K | $-355.0K | $-917.0K | $-169.0K | $-39.0K | $-143.0K | $-240.0K | $-79.0K | $-264.0K | |
| Stock Issued | $739.0K | $-43.0K | $-179.0K | $-45.0K | $0 | $9M | $12M | $20M | $-1.0K | $547.0K | $0 | $0 | $0 | $0 | · | · | |
| Net Stock Activity | · | $-43.0K | · | · | · | $9M | · | · | · | $547.0K | · | · | · | · | · | · | |
| Financing Cash Flow | $1M | $9M | $410.0K | $103.0K | $392.0K | $10M | $14M | $40M | $472.0K | $1M | $16M | $363.0K | $473.0K | $8M | $7M | $7.0K | |
| Net Change in Cash | $-8M | $-3M | $-9M | $-10M | $-8M | $-3M | $6M | $30M | $-10M | $-10M | $8M | $-8M | $-12M | $-3M | $-4M | $-11M | |
| Free Cash Flow | · | $-12M | · | · | · | $-13M | · | · | · | $-12M | · | · | · | $-10M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-13M | · | · | · | $-11M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 87.4% | 87.2% | · | 86.8% | 84.3% | 83.5% | · | 83.2% | 83.9% | 85.0% | · | 83.9% | 84.0% | 83.4% | · | 78.3% | |
| Operating Margin | -82.9% | -82.3% | · | -83.5% | -105.8% | -108.8% | · | -97.3% | -118.3% | -206.4% | · | -90.6% | -123.7% | -152.4% | · | -163.7% | |
| Net Margin | -89.4% | -88.8% | · | -87.6% | -108.4% | -111.5% | · | -98.0% | -118.8% | -206.0% | · | -85.7% | -122.6% | -142.6% | · | -158.9% | |
| Pretax Margin | -89.4% | -88.8% | · | -87.6% | -108.5% | -111.5% | · | -97.6% | -118.5% | -205.7% | · | -85.4% | -122.3% | -142.1% | · | -158.4% | |
| EBITDA Margin | -82.9% | -82.3% | · | -83.5% | -105.8% | -108.8% | · | -97.3% | -118.3% | -206.4% | · | -90.6% | -123.7% | -152.4% | · | -163.7% | |
| ROA | -13.3% | -11.4% | · | -10.8% | -13.7% | -11.7% | · | -11.2% | -13.3% | -19.4% | · | -7.7% | -9.4% | -8.5% | · | -6.4% | |
| ROE | -36.1% | -26.7% | · | -22.7% | -26.0% | -20.3% | · | -17.7% | -19.3% | -26.8% | · | -9.0% | -10.7% | -9.6% | · | -7.2% | |
| ROIC | -16.6% | -13.9% | · | -12.6% | -13.4% | -11.3% | · | -11.4% | -16.6% | -23.3% | · | -9.8% | -11.3% | -10.7% | · | -8.6% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.0 | 10.2 | · | 9.6 | 12.0 | 14.8 | · | 11.3 | 10.1 | 12.2 | · | 14.0 | 12.6 | 15.2 | · | 16.8 | |
| Quick Ratio | 6.7 | 8.6 | · | 8.3 | 10.5 | 13.1 | · | 10.0 | 8.7 | 10.6 | · | 12.1 | 10.9 | 13.8 | · | 15.6 | |
| Debt / Equity | 2.9 | 2.0 | · | 1.0 | 0.9 | 0.7 | · | 0.8 | 0.5 | 0.4 | · | 0.2 | 0.2 | 0.1 | · | · | |
| LT Debt / Equity | 2.9 | 2.0 | · | 1.0 | 0.9 | 0.7 | · | 0.8 | 0.5 | 0.4 | · | 0.2 | 0.2 | 0.1 | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -23.2 | · | -19.1 | -24.4 | -50.7 | · | · |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | |
| Inventory Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | |
| Receivables Turnover | 1.9 | 1.6 | · | 1.7 | 1.7 | 1.4 | · | 1.7 | 1.5 | 1.4 | · | 1.8 | 1.8 | 1.6 | · | 1.4 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.75 | $1.10 | · | $1.83 | $2.22 | $2.66 | · | $2.69 | $2.54 | $3.07 | · | $3.98 | $4.34 | $4.81 | · | $5.75 | |
| Revenue / Share | $0.59 | $0.56 | · | $0.56 | $0.52 | $0.48 | · | $0.59 | $0.55 | $0.51 | · | $0.51 | $0.46 | $0.39 | · | $0.30 | |
| Cash Flow / Share | · | $-0.46 | · | · | · | $-0.49 | · | · | · | $-0.51 | · | · | · | $-0.50 | · | · | |
| Cash / Share | $2.42 | $2.74 | · | $3.25 | $3.63 | $3.94 | · | $4.14 | $3.24 | $3.71 | · | $3.99 | $4.38 | $4.99 | · | $5.34 | |
| EPS (TTM) | $-1.97 | $-2.01 | · | $-1.98 | $-2.06 | $-2.14 | · | $-2.71 | $-2.57 | $-2.48 | · | $-2.05 | $-2.10 | $-2.08 | · | $67.03 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $61M | $59M | · | $56M | $55M | $53M | · | $47M | $44M | $42M | · | $35M | $31M | $26M | · | $19M | |
| Net Income TTM | $-52M | $-53M | · | $-52M | $-52M | $-52M | · | $-58M | $-54M | $-52M | · | $-43M | $-43M | $-43M | · | $-41M | |
| Market Cap | $137M | $250M | · | $211M | $154M | $319M | · | $213M | $260M | $393M | · | $316M | $320M | $193M | · | $192M | |
| Enterprise Value | $131M | $236M | · | $176M | $108M | $265M | · | $162M | $219M | $342M | · | $247M | $244M | $104M | · | · | |
| P/E | -2.6 | -4.7 | · | -4.1 | -2.9 | -5.7 | · | -3.3 | -4.7 | -7.3 | · | -7.4 | -7.4 | -4.5 | · | 0.1 | |
| P/S | 2.2 | 4.2 | · | 3.8 | 2.8 | 6.0 | · | 4.5 | 5.9 | 9.3 | · | 9.0 | 10.4 | 7.3 | · | 10.1 | |
| P/B | 6.9 | 8.6 | · | 4.4 | 2.7 | 4.6 | · | 3.3 | 4.7 | 5.9 | · | 3.8 | 3.6 | 1.9 | · | 1.6 | |
| P / Tangible Book | 6.9 | 8.6 | · | 4.4 | 2.7 | 4.6 | · | 3.3 | 4.7 | 5.9 | · | 3.8 | 3.6 | 1.9 | · | 1.6 | |
| P / Cash Flow | · | -20.6 | · | · | · | -25.0 | · | · | · | -36.1 | · | · | · | -18.8 | · | · | |
| EV / Revenue | 2.1 | 4.0 | · | 3.1 | 2.0 | 5.0 | · | 3.4 | 4.9 | 8.1 | · | 7.0 | 7.9 | 3.9 | · | · | |
| Earnings Yield | -38.3% | -21.2% | · | -24.5% | -35.0% | -17.5% | · | -30.8% | -21.4% | -13.6% | · | -13.5% | -13.6% | -22.3% | · | 718.4% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $57M | $51M | $39M | $22M | $13M |
| 毛利率 % | 85.3% | 83.8% | 84.1% | 77.8% | 72.1% |
| 营业利润率 % | -90.5% | -116.0% | -109.7% | -189.3% | -199.2% |
| 净收入 | $-53M | $-60M | $-41M | $-41M | $-43M |
| 稀释后每股收益 (EPS) | $-2.04 | $-2.65 | $-1.99 | $-2.02 | $-4.16 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 1.3 | 0.7 | 0.4 | 0.1 | 0.0 |
| 流动比率 | 7.6 | 12.1 | 14.3 | 15.2 | 25.6 |
| 速动比率 | 6.5 | 10.7 | 12.5 | 13.8 | 24.5 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-41M | $-41M | $-40M | $-43M | $-29M |
机构持有人 (13F) 95 家申报者 · $87.3M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
95
持有价值
$87.3M
新仓位
8
已退出持仓
18
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 8 (-19 与上一季度对比) | 18 (+5 与上一季度对比) | 35 (+2 与上一季度对比) | 29 (+9 与上一季度对比) | +574K |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| JOHNSON & JOHNSON | $20687786 | 4024861 | 23.70% | 股份 |
| NEA Management Company, LLC | $10045822 | 1954440 | 11.51% | 股份 |
| VANGUARD GROUP INC | $7956707 | 1120663 | 9.12% | 股份 |
| BlackRock, Inc. | $6401661 | 1245459 | 7.33% | 股份 |
| ROYAL BANK OF CANADA | $6338000 | 1233212 | 7.26% | 股份 |
| GSK plc | $5178977 | 1007583 | 5.93% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $4680361 | 910576 | 5.36% | 股份 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $4513480 | 878109 | 5.17% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $2266478 | 440786 | 2.60% | 股份 |
| PFM Health Sciences, LP | $1899600 | 369572 | 2.18% | 股份 |
| STATE STREET CORP | $1883049 | 366352 | 2.16% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $1182200 | 230000 | 1.35% | 股份 |
| UBS Group AG | $1152558 | 224233 | 1.32% | 股份 |
| TUDOR INVESTMENT CORP ET AL | $1057216 | 205684 | 1.21% | 股份 |
| GOLDMAN SACHS GROUP INC | $768476 | 149509 | 0.88% | 股份 |
| MORGAN STANLEY | $745182 | 144977 | 0.85% | 股份 |
| Kestra Advisory Services, LLC | $680536 | 132400 | 0.78% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $680526 | 132398 | 0.78% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $662829 | 128955 | 0.76% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $659866 | 127971 | 0.76% | 股份 |
| NORTHERN TRUST CORP | $641302 | 124767 | 0.73% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $544403 | 105915 | 0.62% | 股份 |
| AQR CAPITAL MANAGEMENT LLC | $542856 | 105614 | 0.62% | 股份 |
| Cresset Asset Management, LLC | $533784 | 103849 | 0.61% | 股份 |
| AlphaQuest LLC | $502645 | 70795 | 0.58% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $500168 | 97309 | 0.57% | 股份 |
| Quantinno Capital Management LP | $423192 | 82333 | 0.48% | 股份 |
| CITADEL ADVISORS LLC | $406127 | 79013 | 0.47% | 股份 |
| Jump Financial, LLC | $398350 | 77500 | 0.46% | 股份 |
| Nuveen, LLC | $254666 | 49546 | 0.29% | 股份 |
| WOLVERINE TRADING, LLC | $228312 | 29346 | 0.26% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $220986 | 23360 | 0.25% | 股份 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $210226 | 40900 | 0.24% | 股份 |
| Bank of New York Mellon Corp | $198641 | 38646 | 0.23% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $181946 | 35398 | 0.21% | 股份 |
| Point72 Asset Management, L.P. | $137613 | 26773 | 0.16% | 股份 |
| XTX Topco Ltd | $112181 | 21825 | 0.13% | 股份 |
| JPMORGAN CHASE & CO | $109932 | 18507 | 0.13% | 股份 |
| Jain Global LLC | $109482 | 21300 | 0.13% | 股份 |
| Mitsubishi UFJ Asset Management Co., Ltd. | $106532 | 20726 | 0.12% | 股份 |
| RBF Capital, LLC | $102800 | 20000 | 0.12% | 股份 |
| BANK OF AMERICA CORP /DE/ | $102085 | 19861 | 0.12% | 股份 |
| RHUMBLINE ADVISERS | $96688 | 18812 | 0.11% | 股份 |
| WELLS FARGO & COMPANY/MN | $85797 | 16692 | 0.10% | 股份 |
| Corton Capital Inc. | $85461 | 10590 | 0.10% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $84476 | 16435 | 0.10% | 股份 |
| Graham Capital Management, L.P. | $76884 | 14958 | 0.09% | 股份 |
| CWM, LLC | $76238 | 8059 | 0.09% | 股份 |
| JANE STREET GROUP, LLC | $69390 | 13500 | 0.08% | 买入期权 |
| R Squared Ltd | $68907 | 13406 | 0.08% | 股份 |
激进投资者及 5%+ 股东 4 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Chernett Jorey ×2 申报 | 2026年10月2日 | 0.62% | 修订 | · | SEC |
| New Enterprise Associates 10, Limited Partnership, New Enterprise Associates 8A, Limited Partnership, NEA Partners 10, Limited Partnership, New Enterprise Associates VIII, Limited Partnership, NEA Partners VIII, Limited Partnership, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell | 2025年2月20日 | 7.80% | 修订 | · | SEC |
| Cooperatieve Gilde Healthcare IV U.A., Gilde Healthcare IV Management B.V., Gilde Healthcare Holding B.V., Manapouri B.V., Martemanshurk B.V. ×4 申报 | 2025年2月6日 | 4.90% | 修订 | · | SEC |
| New Enterprise Associates 8A, Limited Partnership, New Enterprise Associates 10, Limited Partnership, NEA Partners 10, Limited Partnership, New Enterprise Associates VIII, Limited Partnership, NEA Partners VIII, Limited Partnership, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell ×2 申报 | 2024年11月7日 | · | 初始申报 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 25 位内幕人士 · 11 位高管 · 9 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Kevin Hykes | PRES & CEO | 2026年2月27日 A | 284237 | 0 | 1 | $-61328 |
| Nadim Yared | CHIEF EXECUTIVE OFFICER | 2024年2月2日 A | 26255 | 0 | 0 | $0 |
| Jared Oasheim | CHIEF FINANCIAL OFFICER | 2026年2月27日 A | 96703 | 0 | 1 | $-13778 |
| Brent Binkowski | CHIEF OPERATING OFFICER | 2026年8月13日 P | 56514 | 1 | 1 | $72971 |
| Philip B. Adamson | Chief Medical Officer | 2026年2月27日 A | 61578 | 0 | 1 | $-9970 |
| Robert Allen John | Chief Revenue Officer | 2026年2月27日 A | 86036 | 0 | 1 | $-31316 |
| Paul Verrastro | CHIEF MKTG & STRAT OFFICER | 2026年2月27日 A | 60551 | 0 | 1 | $-10144 |
| Craig E. Palmer | SVP, U.S. SALES | 2024年3月25日 M | 1229 | 0 | 0 | $0 |
| Liz Galle | VP OF GLOBAL CLINICAL RESEARCH | 2023年10月16日 M | 778 | 0 | 0 | $0 |
| Dean Bruhn-Ding | VP OF REG. AFFAIRS AND QA | 2022年8月2日 A | 54648 | 0 | 0 | $0 |
| John Brintnall | CHIEF STRATEGY OFFICER AND SEC | 2022年4月22日 M | 21901 | 0 | 0 | $0 |
| Martha Shadan | 董事 | 2026年6月1日 A | 8720 | 0 | 0 | $0 |
| Mitch C. Hill, | 董事 | 2026年6月1日 A | 8720 | 0 | 0 | $0 |
| Mudit K. Jain | 董事 | 2026年6月1日 A | 14370 | 2 | 0 | $300432 |
| Kevin J. Ballinger | 董事 | 2026年6月1日 A | 8720 | 0 | 0 | $0 |
| Kirk Nielsen | 董事 | 2026年6月1日 A | 8720 | 0 | 0 | $0 |
| Ali Behbahani | 董事 | 2024年6月4日 A | 316 | 0 | 0 | $0 |
| John M Nehra | 董事 | 2022年6月7日 A | 28266 | 0 | 0 | $0 |
| Johnson & Johnson Innovation - JJDC, Inc. | 10% 所有者 | 2023年9月15日 J | 0 | 0 | 0 | $0 |
| New Enterprise Associates 10, Limited Partnership | 10% 所有者 | 2021年7月2日 C | 2026083 | 0 | 0 | $0 |
| Joseph P Slattery | · | 2026年6月1日 A | 39365 | 0 | 0 | $0 |
| DALE MICHAEL D | · | 2026年6月1日 A | 29005 | 0 | 0 | $0 |
| Gregory Morrison | · | 2026年3月2日 A | 34000 | 0 | 0 | $0 |
| Geoffrey B Pardo | · | 2021年7月2日 C | 1829022 | 0 | 0 | $0 |
| GSK plc | · | 2021年7月2日 C | 1007583 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 14 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| IWC · iShares Trust | 0.01% | 51258 SH | 2026年9月11日 | 每日 |
| IWO · iShares Trust | 0.00% | 156004 SH | 2026年9月11日 | 每日 |
| RSSL · Global X Funds | 0.00% | 7352 NS | 2026年7月31日 | N-PORT |
| IWM · iShares Trust | 0.00% | 364840 SH | 2026年9月11日 | 每日 |
| DFAS · Dimensional ETF Trust | 0.00% | 28363 NS | 2026年7月31日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 1354 NS | 2026年7月31日 | N-PORT |
| IWV · iShares Trust | 0.00% | 5299 SH | 2026年9月3日 | 每日 |
| DFAC · Dimensional ETF Trust | 0.00% | 5367 NS | 2026年7月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 204533 SH | 2026年8月19日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 684121 SH | 2026年8月19日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.00% | 89003 SH | 2026年8月19日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.00% | 15722 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 1190 SH | 2026年8月19日 | 每日 |
| DXUV · Dimensional ETF Trust | 0.00% | 4 NS | 2026年7月31日 | N-PORT |
CVRX 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 13 位分析师
买入
中位数目标
$4.50
+190.3%
3 23.1%
强烈买入
6 46.2%
买入
3 23.1%
持有
1 7.7%
卖出
0 0.0%
强烈卖出
12个月价格目标
6 位分析师 · 2026-10-03平均目标 $4.58 +195.7%
← 低于所有目标
当前价格 $1.55
最低$3.50
平均值$4.58
最高$6.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| CVRX | $187M | -3.5 | 10.4% | -94.1% | -109.6% | 85.3% |
| MDAI | · | · | · | · | · | · |
| ODYS | $54M | -3.1 | -23.9% | -565.0% | -58.7% | 28.9% |
| SRTS | $66M | -8.5 | -34.3% | -28.1% | -15.4% | 43.2% |
| POCI | $56M | -11.9 | 65.2% | -11.5% | -24.5% | 17.2% |
| SNWV | $256M | 72.8 | 35.0% | 26.8% | -395.5% | 77.1% |
| QTI | $73M | -3.0 | 287.9% | -111.4% | -688.9% | 45.4% |
| ARAY | $31M | -0.9 | -12.3% | -12.2% | -103.4% | 27.7% |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 6, 2026 申报